NEW YORK –A public-private consortium in Israel will collect samples and sequence genomes from thousands of COVID-19 patients in an effort to identify protective and risk-bearing genetic factors with the hopes of discovering new diagnostic and treatment methods.

“This is a rare opportunity to thoroughly and consistently document clinical findings of thousands of patients and sequence their whole genome.”

Dr. Hagit Baris Feldman, director of the Genetic Institute and Genomic Center at Ichilov

Consortium partners include the Israel Ministry of Health, the Israel Innovation Authority, Sourasky (Ichilov) Medical Center, Rambam Health Care Campus, and startup company Geneyx, which offers next-generation sequencing data analysis, interpretation, reporting, and storage products and services.

Request A Demo